This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n4http://linked.opendata.cz/resource/drugbank/drug/DB08113/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB08113/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08113/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08113/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08113
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB08113 n13:DB08113
dcterms:title
3-pyridin-4-yl-1H-indazole
adms:identifier
n4:LL1 n5:12412578 n8:DB08113 n11:99444584
n6:IUPAC-Name
n7:271B5F7D-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5F83-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5F82-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5F7F-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5F80-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5F81-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5F7B-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5F79-363D-11E5-9242-09173F13E4C5 n7:271B5F7C-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5F7A-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5F89-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5F8A-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5F84-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5F85-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5F87-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5F86-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5F88-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5F8F-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5F91-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5F92-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5F8E-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5F8D-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5F90-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5F7E-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B5F8B-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5F8C-363D-11E5-9242-09173F13E4C5